title: Moving beyond sorafenib alone in advanced hepatocellular carcinoma: is hepatic arterial infusion chemotherapy the best option?
authors.affiliation: Units of Medical Oncology 2; 2Radiology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Fornaro
authors.affiliation: Units of Medical Oncology 2; 2Radiology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Vivaldi
authors.affiliation: Units of Medical Oncology 2; 2Radiology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Lorenzoni
authors.affiliation: Units of Medical Oncology 2; 2Radiology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Masi
authors.affiliation: Units of Medical Oncology 2; 2Radiology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Bargellini
mesh_terms: D006528:Carcinoma, Hepatocellular; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D000077157:Sorafenib
chemical_list: D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib